Stocksigma LogoStocksigma Logo

Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

■ Revenue: 14,214 (+16.8% YoY | +13.2% QoQ) ■ EBITDA: 3,193 (+73.5% YoY | +21.8% QoQ) ■ EBITDA Margin (%): 22.5 (+735 bps YoY | +159 bps QoQ) ■ PAT: 2,665

Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh)

Syncom Formulations India Ltd · Outcome · 13 Nov 2026, 10:16 pm

Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) ■ Revenue: 14,214 (+16.8% YoY | +13.2% QoQ) ■ EBITDA: 3,193 (+73.5% YoY | +21.8% QoQ) ■ EBITDA Margin (%): 22.5 (+735 bps YoY | +159 bps QoQ) ■ PAT: 2,665 (+60.6% YoY | +7.3% QoQ) ■ EPS (INR): 0.28 (+55.6% YoY | +7.7% QoQ) Syncom Formulations India Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakh) Segmental Performance Pharmaceuticals Drugs & Formulations ■ Revenue: 14,679 (+16.5% YoY | +11.0% QoQ) ■ EBIT: 3,518 (+65.0% YoY | +11.0% QoQ) ■ EBIT Margin (%): 24.0 (+705 bps YoY | -1 bps QoQ) Trading of Commodities ■ Revenue: 14.4 (-48.1% QoQ) ■ EBIT: 7.5 (+276.4% QoQ) ■ EBIT Margin (%): 51.9 (+4472 bps QoQ) Renting of Property ■ Revenue: 128 (+29.1% YoY | +51.6% QoQ) ■ EBIT: 118 (+19.8% YoY | +52.9% QoQ) ■ EBIT Margin (%): 92.8 (-717 bps YoY | +79 bps QoQ)

Original exchange filing (PDF)

More announcements from Syncom Formulations India Ltd

All Syncom Formulations India Ltd announcements